CoVigator—A Knowledge Base for Navigating SARS-CoV-2 Genomic Variants
Viruses · 2023
DOI: 10.3390/v15061391 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Thomas Bukur und 8 weiteren Autor:innen. Beteiligte Einrichtung: TRON-Translational Oncology at the Medical Center of the Johannes Gutenberg-University Mainz Gemeinnützige GmbH, 55131 Mainz, Germany. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BioNTech SE, Intel’s Pandemic Response Technology Initiative.
Abstract (Originalsprache)
Background
The outbreak of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) resulted in the global COVID-19 pandemic. The urgency for an effective SARS-CoV-2 vaccine has led to the development of the first series of vaccines at unprecedented speed. The discovery of SARS-CoV-2 spike-glycoprotein mutants, however, and consequentially the potential to escape vaccine-induced protection and increased infectivity, demonstrates the persisting importance of monitoring SARS-CoV-2 mutations to enable early detection and tracking of genomic variants of concern.
Results
We developed the CoVigator tool with three components: (1) a knowledge base that collects new SARS-CoV-2 genomic data, processes it and stores its results; (2) a comprehensive variant calling pipeline; (3) an interactive dashboard highlighting the most relevant findings. The knowledge base routinely downloads and processes virus genome assemblies or raw sequencing data from the COVID-19 Data Portal (C19DP) and the European Nucleotide Archive (ENA), respectively. The results of variant calling are visualized through the dashboard in the form of tables and customizable graphs, making it a versatile tool for tracking SARS-CoV-2 variants. We put a special emphasis on the identification of intrahost mutations and make available to the community what is, to the best of our knowledge, the largest dataset on SARS-CoV-2 intrahost mutations. In the spirit of open data, all CoVigator results are available for download. The CoVigator dashboard is accessible via covigator.tron-mainz.de.
Conclusions
With increasing demand worldwide in genome surveillance for tracking the spread of SARS-CoV-2, CoVigator will be a valuable resource of an up-to-date list of mutations, which can be incorporated into global efforts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- TRON-Translational Oncology at the Medical Center of the Johannes Gutenberg-University Mainz Gemeinnützige GmbH, 55131 Mainz, Germany.
- BioNTech SE, 55131 Mainz, Germany.
- Research Center for Immunotherapy (FZI), University Medical Center of the Johannes Gutenberg University Mainz, 55099 Mainz, Germany.
ORCID-Profile: Thomas Bukur, Pablo Riesgo-Ferreiro, Barbara Schrörs
Förderung
- BioNTech SE
- Intel’s Pandemic Response Technology Initiative
Zitieren
APA
Bukur, T., Riesgo-Ferreiro, P., Sorn, P., Gudimella, R., Hausmann, J., Rösler, T., Löwer, M., Schrörs, B., & Sahin, U. (2023). CoVigator—A Knowledge Base for Navigating SARS-CoV-2 Genomic Variants. Viruses. https://doi.org/10.3390/v15061391
Vancouver
Bukur T, Riesgo-Ferreiro P, Sorn P, Gudimella R, Hausmann J, Rösler T, et al. CoVigator—A Knowledge Base for Navigating SARS-CoV-2 Genomic Variants. Viruses. 2023. doi:10.3390/v15061391
BibTeX
@article{Bukur2023,
author = {Bukur, Thomas and Riesgo-Ferreiro, Pablo and Sorn, Patrick and Gudimella, Ranganath and Hausmann, Johannes and Rösler, Thomas and Löwer, Martin and Schrörs, Barbara and Sahin, Ugur},
title = {CoVigator—A Knowledge Base for Navigating SARS-CoV-2 Genomic Variants},
journal = {Viruses},
year = {2023},
doi = {10.3390/v15061391}
}
EUVIMED